0002128979-26-000001.txt : 20260430 0002128979-26-000001.hdr.sgml : 20260430 20260430115300 ACCESSION NUMBER: 0002128979-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260430 DATE AS OF CHANGE: 20260430 EFFECTIVENESS DATE: 20260430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Parabolica Therapeutics, Inc. CENTRAL INDEX KEY: 0002128979 ORGANIZATION NAME: EIN: 412656577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-582381 FILM NUMBER: 26921787 BUSINESS ADDRESS: STREET 1: 6738 NORTHPORT DR CITY: DALLAS STATE: TX ZIP: 75230 BUSINESS PHONE: 6462657608 MAIL ADDRESS: STREET 1: 6738 NORTHPORT DR CITY: DALLAS STATE: TX ZIP: 75230 D 1 primary_doc.xml X0708 D LIVE 0002128979 Parabolica Therapeutics, Inc. 6738 NORTHPORT DR DALLAS TX TEXAS 75230 6462657608 DELAWARE None None Corporation true 2025 Andrew Wang 6738 NORTHPORT DR Dallas TX TEXAS 75230 Executive Officer Director Narendra Chokshi 6738 NORTHPORT DR DALLAS TX TEXAS 75230 Executive Officer Director Brian J. Brille 6738 NORTHPORT DR DALLAS TX TEXAS 75230 Director Biotechnology Decline to Disclose 06b false 2026-03-30 false true Simple Agreement for Future Equity false 0 250000 50000 200000 false 2 0 0 0 Other than the payment of salaries and other compensation benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Parabolica Therapeutics, Inc. /s/ Andrew Wang Andrew Wang Chief Executive Officer 2026-04-29